Eur Rev Med Pharmacol Sci 2019; 23 (20): 8841-8851

DOI: 10.26355/eurrev_201910_19279

Preliminary proteomic analysis of radiation response markers in rectal cancer patients

W.-Q. Shen, G.-Q. Rong, Y. Wu, Y.-W. Pu, Z.-Y. Ye, C. Cao, X.-D. Yang, C.-G. Xing

Department of General Surgery, the Second Affiliated Hospital of Soochow University, Suzhou, China. xingcg@126.com


OBJECTIVE: To provide biomarkers related to the radiation response of patients to avoid unnecessary side effects on those who were not sensitive to radiotherapy.
PATIENTS AND METHODS: In the present study, we compared the different four proteins (PDIA3, Vimentin, Galectin3, Dhe3) patterns in rectal tumor tissue before and after radiation therapy by using 2-D PAGE, mass spectrometry, and bioinformatics analysis.
RESULTS: The protein level of Galectin3 and PDIA3 were downregulated in rectal cancer patients before and after radiotherapy (1.42 folds); while Dhe3 protein and Vimentin were upregulated (1-2 folds), and we also revealed Vimentin as its role in the negative regulation of the well-known transcription factor ATF4.
CONCLUSIONS: Our study showed that four candidate proteins, including PIDA3, Galectin3, Dhe3, and Vimentin, might be the potential biomarkers in the identification of radiation response in rectal cancer.

Free PDF Download

To cite this article

W.-Q. Shen, G.-Q. Rong, Y. Wu, Y.-W. Pu, Z.-Y. Ye, C. Cao, X.-D. Yang, C.-G. Xing
Preliminary proteomic analysis of radiation response markers in rectal cancer patients

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 20
Pages: 8841-8851
DOI: 10.26355/eurrev_201910_19279